Page last updated: 2024-11-12

flubendiamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

flubendiamide: activates ryanodine-sensitive calcium release channels in insects; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11193251
CHEMBL ID563789
CHEBI ID38798
SCHEMBL ID27362
MeSH IDM0496120

Synonyms (38)

Synonym
272451-65-7
CHEBI:38798 ,
n(2)-[1,1-dimethyl-2-(methylsulfonyl)ethyl]-3-iodo-n(1)-{2-methyl-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl}benzene-1,2-dicarboxamide
n(2)-[1,1-dimethyl-2-(methylsulfonyl)ethyl]-3-iodo-n(1)-{2-methyl-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl}phthalamide
flubendiamide
CHEMBL563789
flubendiamide [iso]
3-iodo-n-(2-methanesulfonyl-1,1-dmethylethyl)-n'-(2-methyl-4-(1,2,2,2-tetrafluoro-1-trifluoromethylethyl)phenyl)phthalamide
unii-gev84zi4k6
hsdb 7883
gev84zi4k6 ,
C18520
cas-272451-65-7
dtxcid2027672
tox21_303432
NCGC00257277-01
dtxsid4047672 ,
3-iodo-n2-(2-methyl-1-(methylsulfonyl)propan-2-yl)-n1-(2-methyl-4-(perfluoropropan-2-yl)phenyl)phthalamide
AKOS016007707
nni-0001
3-iodo-n'-(2-mesyl-1,1-dimethylethyl)-n-(4-(1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl)-o-tolyl)phthalamide
3-iodo-n1-(2-mesyl-1,1-dimethylethyl)-n-(4-(1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl)-o-tolyl)phthalamide
fenos
flubendiamide [mi]
synapse
n(sup 2)-(1,1-dimethyl-2-(methylsulfonyl)ethyl)-3-iodo-n(sup 1)-(2-methyl-4-(1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl)phenyl)-1,2-benzenedicarboxamide
1,2-benzenedicarboxamide, n2-(1,1-dimethyl-2-(methylsulfonyl)ethyl)-3-iodo-n1-(2-methyl-4-(1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl)phenyl)-
fame
SCHEMBL27362
flubendiamide, pestanal(r), analytical standard
flubendiamde
bdbm50488569
J-016707
1-n-[4-(1,1,1,2,3,3,3-heptafluoropropan-2-yl)-2-methylphenyl]-3-iodo-2-n-(2-methyl-1-methylsulfonylpropan-2-yl)benzene-1,2-dicarboxamide
Q17300229
flubendiamide 100 microg/ml in acetonitrile
CS-0450557
1,2-benzenedicarboxamide, n2-[1,1-dimethyl-2-(methylsulfonyl)ethyl]-3-iodo-n1-[2-methyl-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl]-

Research Excerpts

Overview

Flubendiamide (FLB) is an insecticide that is commonly employed to control pests on a variety of vegetables and fruits, with low toxicity for non-target organisms. It is a phthalic acid diamide insecticides that ceases the function of insect muscle leading to paralysis and death.

ExcerptReferenceRelevance
"Flubendiamide is a new class of chemical pesticide with broad spectrum activity against lepidopteran pests. "( Detection of trizole contaminated waste water using biocatalyst and effective biodegradation potential of flubendiamide.
Abbasi, AM; Al-Mohaimeed, AM; Ali, MA; Shazhni, JRA, 2022
)
2.38
"Flubendiamide is a widely used diamide insecticide with many adverse effects on environmental organisms. "( Bioaccumulation and toxicity effects of flubendiamide in zebrafish (Danio rerio).
Chen, X; Cui, J; Fan, T; Meng, Z; Song, Y; Teng, M; Wang, Z; Xu, W; Zheng, Y, 2022
)
2.43
"Flubendiamide (FLB) is an insecticide that is commonly employed to control pests on a variety of vegetables and fruits, with low toxicity for non-target organisms. "( Cyto-Genotoxic and Behavioral Effects of Flubendiamide in
Akyıl, D; Bonciu, E; Ciğerci, İH; Colă, F; İstifli, ES; Liman, R; Özkara, A, 2023
)
2.62
"Flubendiamide is a phthalic acid diamide insecticide that ceases the function of insect muscle leading to paralysis and death."( Flubendiamide induced genetic and cellular damages directly influence the life cycle of the oriental leaf worm, Spodoptera litura.
Alam, MF; Fatma, H; Jamal, K; Jameel, M; Javed, S; Khan, MA; Qureshi, MA; Siddique, HR; Singh, D; Younus, H, 2023
)
3.07
"Flubendiamide is a phthalic diamide insecticide that shows selective insecticidal activity against lepidopterous insects."( Susceptibility of the rice stem borer, Chilo suppressalis (Lepidoptera: Crambidae), to flubendiamide in China.
Gao, C; Su, J; Wu, M; Wu, S; Yao, R; Zhang, S, 2014
)
1.35
"Flubendiamide is a benzenedicarboxamide derivative that shows selective insecticidal activity against lepidopterous insects. "( Molecular characterization of flubendiamide sensitivity in the lepidopterous ryanodine receptor Ca(2+) release channel.
Hamachi, I; Inoue, K; Kato, K; Kiyonaka, S; Masaki, T; Mizuno, Y; Mori, E; Mori, Y; Sawaguchi, Y; Takeshima, H; Tohnishi, M; Yasokawa, N, 2009
)
2.08
"Flubendiamide is a new insecticide that has been found to give excellent control of lepidopterous pests of tomato. "( Development of an analytical method for analysis of flubendiamide, des-iodo flubendiamide and study of their residue persistence in tomato and soil.
Ahuja, AK; Deepa, M; Jagadish, GK; Mohapatra, S; Rashmi, N; Sharma, D, 2011
)
2.06

Treatment

Flubendiamide treatment enhanced triglyceride content in 3T3-L1 adipocytes. It also increased the expression of cytosine-cytosine,adenosine-thymidine (CCAAT) and peroxisome proliferator-activated receptor gamma-γ.

ExcerptReferenceRelevance
"Flubendiamide treatment not only enhanced triglyceride content in 3T3-L1 adipocytes, but also increased the expression of cytosine-cytosine-adenosine-adenosine-thymidine (CCAAT)/enhancer-binding protein α and peroxisome proliferator-activated receptor gamma-γ, two important regulators of adipocyte differentiation."( Flubendiamide Enhances Adipogenesis and Inhibits AMPKα in 3T3-L1 Adipocytes.
Gao, R; Lin, J; Peng, Y; Sun, Q, 2018
)
2.64
"Flubendiamide-treated soil showed a non-significantly decreasing trend of soil MBC with time up to the 15th day of incubation and after 15 days significantly decreased up to 90 days of incubation."( Degradation of flubendiamide as affected by elevated CO2, temperature, and carbon mineralization rate in soil.
Das, SK; Kumar, A; Mukherjee, I, 2016
)
1.51

Toxicity

ExcerptReferenceRelevance
" The evaluation of the chorion of the eggshell in this study has clarified the toxic effect of methomyl and cartap hydrochloride on eggs."( Insecticide toxicity to the borer Neoleucinodes elegantalis (Guenée) (Lepidoptera: Crambidae): developmental and egg-laying effects.
Arcanjo, LP; Costa, ÁH; Ferreira, DO; Martins, JC; Picanço, MC; Serrão, JE; Silva, RS; Soares, JRS, 2018
)
0.48
" These xenobiotics interact individually or in combination with biological systems and act as carcinogen or produce other toxic effects including reproductive and degenerative diseases."( In vitro and in vivo effects of flubendiamide and copper on cyto-genotoxicity, oxidative stress and spleen histology of rats and its modulation by resveratrol, catechin, curcumin and α-tocopherol.
Garg, SK; Kumar, R; Mandil, R; Prakash, A; Rahal, A; Sharma, D; Singh, SP, 2020
)
0.84
"Flubendiamide is a widely used diamide insecticide with many adverse effects on environmental organisms."( Bioaccumulation and toxicity effects of flubendiamide in zebrafish (Danio rerio).
Chen, X; Cui, J; Fan, T; Meng, Z; Song, Y; Teng, M; Wang, Z; Xu, W; Zheng, Y, 2022
)
2.43
" However, the underlying toxic mechanisms remain unclear."( Evaluation of the Two Typical Diamide Insecticide-Induced Oxidative Damages and the Molecular Mechanism Underlying Their Toxicity in
Du, F; Feng, CX; Hou, X; Zhou, DF, 2023
)
0.91

Pharmacokinetics

ExcerptReferenceRelevance
" Following flubendiamide exposure, most of the pharmacokinetic parameters of cefquinome were significantly altered in buffalo calves."( Pharmacokinetic profile of cefquinome after oral subchronic flubendiamide exposure and in vitro plasma protein binding in buffalo calves.
Dumka, VK; Venkatachalam, D, 2015
)
1.05
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
ryanodine receptor modulatornull
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
organofluorine insecticide
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (15)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency41.95370.006038.004119,952.5996AID1159521; AID1159523
GLI family zinc finger 3Homo sapiens (human)Potency6.10650.000714.592883.7951AID1259368; AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency13.13330.000221.22318,912.5098AID743035; AID743063
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency10.93600.001022.650876.6163AID1224838
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency34.48130.001530.607315,848.9004AID1224841; AID1224842; AID1224848; AID1224849; AID1259401; AID1259403
farnesoid X nuclear receptorHomo sapiens (human)Potency36.95350.375827.485161.6524AID743239
pregnane X nuclear receptorHomo sapiens (human)Potency13.76760.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency19.16020.000229.305416,493.5996AID743078; AID743079
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency40.67450.001024.504861.6448AID743227
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency41.53120.023723.228263.5986AID743222; AID743241
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency34.88630.057821.109761.2679AID1159526
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency16.57520.000323.4451159.6830AID743065; AID743066; AID743067
heat shock protein beta-1Homo sapiens (human)Potency43.91930.042027.378961.6448AID743210; AID743228
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency38.80230.000627.21521,122.0200AID743202; AID743219
Cellular tumor antigen p53Homo sapiens (human)Potency48.84930.002319.595674.0614AID651631
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (124)

Processvia Protein(s)Taxonomy
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (34)

Processvia Protein(s)Taxonomy
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (19)

Processvia Protein(s)Taxonomy
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (23)

Assay IDTitleYearJournalArticle
AID1112581Insecticidal activity against Myzus persicae (green peach aphid) assessed as mortality by greenhouse assay2012Bioorganic & medicinal chemistry letters, Jun-01, Volume: 22, Issue:11
Novel diamide insecticides: sulfoximines, sulfonimidamides and other new sulfonimidoyl derivatives.
AID1081711Insecticidal activity against third-instar larval stage of Plutella xylostella (diamondback moth) in cabbage leaves assessed as mortality at 1 ug/ml treated for 10 secs before larva infestation measured for 3 days by dipping method2010Journal of agricultural and food chemistry, Oct-27, Volume: 58, Issue:20
Synthesis, insecticidal activity, and structure-activity relationship of trifluoromethyl-containing phthalic acid diamide structures.
AID1081715Insecticidal activity against third-instar larval stage of Plutella xylostella (diamondback moth) in cabbage leaves assessed as mortality at 10 ug/ml treated for 10 secs before larva infestation measured after 2 days by dipping method2010Journal of agricultural and food chemistry, Oct-27, Volume: 58, Issue:20
Synthesis, insecticidal activity, and structure-activity relationship of trifluoromethyl-containing phthalic acid diamide structures.
AID1112582Insecticidal activity against Plutella xylostella (diamondback moth) assessed as mortality by greenhouse assay2012Bioorganic & medicinal chemistry letters, Jun-01, Volume: 22, Issue:11
Novel diamide insecticides: sulfoximines, sulfonimidamides and other new sulfonimidoyl derivatives.
AID420806Activation of ryanodine receptor-mediated calcium release in Heliothis virescens neurons2009Bioorganic & medicinal chemistry, Jun-15, Volume: 17, Issue:12
New and selective ryanodine receptor activators for insect control.
AID420801Octanol-water partition coefficient, log P at 24.9 degC2009Bioorganic & medicinal chemistry, Jun-15, Volume: 17, Issue:12
New and selective ryanodine receptor activators for insect control.
AID1889449Larvicidal activity against Plutella xylostella assessed as mortality and measured upto 4 days2022Journal of natural products, 02-25, Volume: 85, Issue:2
Tigliane Diterpenoids with Larvicidal, Antifungal, and α-Glucosidase Inhibitory Activities from
AID1081710Insecticidal activity against third-instar larval stage of Plutella xylostella (diamondback moth) in cabbage leaves assessed as mortality at 0.5 ug/ml treated for 10 secs before larva infestation measured for 3 days by dipping method2010Journal of agricultural and food chemistry, Oct-27, Volume: 58, Issue:20
Synthesis, insecticidal activity, and structure-activity relationship of trifluoromethyl-containing phthalic acid diamide structures.
AID1081709Insecticidal activity against third-instar larval stage of Plutella xylostella (diamondback moth) in cabbage leaves assessed as mortality at 0.1 ug/ml treated for 10 secs before larva infestation measured for 3 days by dipping method2010Journal of agricultural and food chemistry, Oct-27, Volume: 58, Issue:20
Synthesis, insecticidal activity, and structure-activity relationship of trifluoromethyl-containing phthalic acid diamide structures.
AID1112592Displacement of [3H]-Tritium-N-(4-chloro-2-methyl-6-(methylcarbamoyl)phenyl)-1-(3-chloropyridin-2-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide from Spodoptera littoralis ryanodine receptor2012Bioorganic & medicinal chemistry letters, Jun-01, Volume: 22, Issue:11
Novel diamide insecticides: sulfoximines, sulfonimidamides and other new sulfonimidoyl derivatives.
AID1081533Insecticidal activity against adult Myzus persicae (green peach aphid) in compound treated cabbage leaves assessed as mortality at 25 degC and 85% RH for 24 hr2010Journal of agricultural and food chemistry, Jun-09, Volume: 58, Issue:11
Design, synthesis, and insecticidal activities of phthalamides containing a hydrazone substructure.
AID1112589Lipophilicity, log P of the compound2012Bioorganic & medicinal chemistry letters, Jun-01, Volume: 22, Issue:11
Novel diamide insecticides: sulfoximines, sulfonimidamides and other new sulfonimidoyl derivatives.
AID1112593Insecticidal activity against Plutella xylostella (diamondback moth) third-instar larvae reared on 10 ug/mL compound pre-treated cabbage leaf disks assessed as insect mortality measured after 3 days post compound treatment by leaf dipping method2012Pest management science, Jul, Volume: 68, Issue:7
Design, synthesis, insecticidal activity and structure-activity relationship of 3,3-dichloro-2-propenyloxy-containing phthalic acid diamide structures.
AID420800Solubility in water at 20 degC2009Bioorganic & medicinal chemistry, Jun-15, Volume: 17, Issue:12
New and selective ryanodine receptor activators for insect control.
AID1081716Insecticidal activity against third-instar larval stage of Plutella xylostella (diamondback moth) in cabbage leaves assessed as mortality at 100 ug/ml treated for 10 secs before larva infestation measured after 2 days by dipping method2010Journal of agricultural and food chemistry, Oct-27, Volume: 58, Issue:20
Synthesis, insecticidal activity, and structure-activity relationship of trifluoromethyl-containing phthalic acid diamide structures.
AID1081713Insecticidal activity against third-instar larval stage of Plutella xylostella (diamondback moth) in cabbage leaves assessed as mortality at 10 ug/ml treated for 10 secs before larva infestation measured after 3 days by dipping method2010Journal of agricultural and food chemistry, Oct-27, Volume: 58, Issue:20
Synthesis, insecticidal activity, and structure-activity relationship of trifluoromethyl-containing phthalic acid diamide structures.
AID1112591Displacement of [3H]-Tritium-N-(4-chloro-2-methyl-6-(methylcarbamoyl)phenyl)-1-(3-chloropyridin-2-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide from Myzus persicae (green peach aphid) ryanodine receptor2012Bioorganic & medicinal chemistry letters, Jun-01, Volume: 22, Issue:11
Novel diamide insecticides: sulfoximines, sulfonimidamides and other new sulfonimidoyl derivatives.
AID1081712Insecticidal activity against third-instar larval stage of Plutella xylostella (diamondback moth) in cabbage leaves assessed as mortality at 5 ug/ml treated for 10 secs before larva infestation measured for 3 days by dipping method2010Journal of agricultural and food chemistry, Oct-27, Volume: 58, Issue:20
Synthesis, insecticidal activity, and structure-activity relationship of trifluoromethyl-containing phthalic acid diamide structures.
AID1112583Insecticidal activity against Spodoptera littoralis assessed as mortality by greenhouse assay2012Bioorganic & medicinal chemistry letters, Jun-01, Volume: 22, Issue:11
Novel diamide insecticides: sulfoximines, sulfonimidamides and other new sulfonimidoyl derivatives.
AID1112596Insecticidal activity against Plutella xylostella (diamondback moth) third-instar larvae reared on 100 ug/mL compound pre-treated cabbage leaf disks assessed as insect mortality measured after 2 days post compound treatment by leaf dipping method2012Pest management science, Jul, Volume: 68, Issue:7
Design, synthesis, insecticidal activity and structure-activity relationship of 3,3-dichloro-2-propenyloxy-containing phthalic acid diamide structures.
AID1112594Insecticidal activity against Plutella xylostella (diamondback moth) third-instar larvae reared on 10 ug/mL compound pre-treated cabbage leaf disks assessed as insect mortality measured after 2 days post compound treatment by leaf dipping method2012Pest management science, Jul, Volume: 68, Issue:7
Design, synthesis, insecticidal activity and structure-activity relationship of 3,3-dichloro-2-propenyloxy-containing phthalic acid diamide structures.
AID1112590Aqueous solubility of the compound at pH 72012Bioorganic & medicinal chemistry letters, Jun-01, Volume: 22, Issue:11
Novel diamide insecticides: sulfoximines, sulfonimidamides and other new sulfonimidoyl derivatives.
AID1081708Insecticidal activity against third-instar larval stage of Plutella xylostella (diamondback moth) in cabbage leaves assessed as mortality treated for 10 secs before larva infestation measured for 3 days by dipping method2010Journal of agricultural and food chemistry, Oct-27, Volume: 58, Issue:20
Synthesis, insecticidal activity, and structure-activity relationship of trifluoromethyl-containing phthalic acid diamide structures.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (97)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's10 (10.31)29.6817
2010's66 (68.04)24.3611
2020's21 (21.65)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 39.36

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index39.36 (24.57)
Research Supply Index4.61 (2.92)
Research Growth Index5.31 (4.65)
Search Engine Demand Index92.44 (26.88)
Search Engine Supply Index3.32 (0.95)

This Compound (39.36)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (2.02%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other97 (97.98%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]